Dr Robert Joseph Defatta, MD, PH D, FACS - Medicare Otolaryngology in Altoona, WI

Dr Robert Joseph Defatta, MD, PH D, FACS is a medicare enrolled "Otolaryngology" physician in Altoona, Wisconsin. He went to Louisiana State University School Of Medicine In New Orleans and graduated in 2002 and has 22 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Defatta Ent And Facial Plastic Surgery Sc and his current practice location is 1490 Rivers Edge Trail, Altoona, Wisconsin. You can reach out to his office (for appointments etc.) via phone at (715) 828-2368.

Dr Robert Joseph Defatta is licensed to practice in Wisconsin (license number 55984-20) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1578697520.

Contact Information

Dr Robert Joseph Defatta, MD, PH D, FACS
1490 Rivers Edge Trail,
Altoona, WI 54720-1495
(715) 828-2368
Not Available



Physician's Profile

Full NameDr Robert Joseph Defatta
GenderMale
SpecialityOtolaryngology
Experience22 Years
Location1490 Rivers Edge Trail, Altoona, Wisconsin
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Robert Joseph Defatta attended and graduated from Louisiana State University School Of Medicine In New Orleans in 2002
  NPI Data:
  • NPI Number: 1578697520
  • Provider Enumeration Date: 03/14/2007
  • Last Update Date: 12/20/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0345335675
  • Enrollment ID: I20111205000260

Medical Identifiers

Medical identifiers for Dr Robert Joseph Defatta such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1578697520NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Y00000XOtolaryngology 243412 (New York)Secondary
207YP0228XOtolaryngology - Pediatric Otolaryngology 243412 (New York)Secondary
207YP0228XOtolaryngology - Pediatric Otolaryngology 55984 (Wisconsin)Secondary
207YS0012XOtolaryngology - Sleep Medicine 243412 (New York)Secondary
207YS0012XOtolaryngology - Sleep Medicine 55984 (Wisconsin)Secondary
207YS0123XOtolaryngology - Facial Plastic Surgery 243412 (New York)Secondary
207YS0123XOtolaryngology - Facial Plastic Surgery 55984 (Wisconsin)Secondary
207YX0007XOtolaryngology - Plastic Surgery Within The Head & Neck 55984 (Wisconsin)Secondary
207YX0007XOtolaryngology - Plastic Surgery Within The Head & Neck 243412 (New York)Secondary
207YX0602XOtolaryngology - Otolaryngic Allergy 243412 (New York)Secondary
207YX0602XOtolaryngology - Otolaryngic Allergy 55984 (Wisconsin)Secondary
207YX0901XOtolaryngology - Otology & Neurotology 243412 (New York)Secondary
207YX0901XOtolaryngology - Otology & Neurotology 55984 (Wisconsin)Secondary
207YX0905XOtolaryngology - Otolaryngology/facial Plastic Surgery 243412 (New York)Secondary
207Y00000XOtolaryngology 55984-20 (Wisconsin)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Sacred Heart HospitalEau claire, WIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Defatta Ent And Facial Plastic Surgery Sc61030599364

News Archive

Alexza enters into agreement with institutional investors to raise $19.7 million

Alexza Pharmaceuticals, Inc. announced today that it has entered into a definitive agreement with various institutional investors to raise $19.7 million in a private placement of its common stock.

Nomir publishes efficacy of the Noveondual-wavelength device against infectious disease pathogens

Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced today the publication of a scientific paper in the journal Photochemistry and Photobiology that details in vitro and human data demonstrating the unique and patented mechanism-of-action for its Noveon® dual-wavelength device, as well as positive efficacy and safety data.

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

The Icahn School of Medicine at Mount Sinai has launched an international clinical trial called TWILIGHT to test the safety and effectiveness of treating coronary stent patients with the anti-clotting medication ticagrelor alone, instead of combining it with aspirin, which is the current standard of care. Researchers will analyze the potential benefits of administering ticagrelor to reduce clotting while at the same time reducing the risk of bleeding associated with the use of both medications.

Components of insulin-control system can reset body's biological clock

Many of the genes that regulate insulin also alter the timing of the circadian clock, a new study has found.

LSTM professor awarded The Manson Medal for outstanding contribution in field of tropical medicine

The Liverpool School of Tropical Medicine (LSTM) is delighted that Emeritus Professor and Senior Professional Fellow, David Molyneux, has been awarded The Manson Medal, the Royal Society of Tropical Medicine and Hygiene's highest mark of distinction.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Robert Joseph Defatta allows following entities to bill medicare on his behalf.
Entity NameDefatta Ent & Facial Plastic Surgery Sc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346664059
PECOS PAC ID: 6103059936
Enrollment ID: O20140502000083

News Archive

Alexza enters into agreement with institutional investors to raise $19.7 million

Alexza Pharmaceuticals, Inc. announced today that it has entered into a definitive agreement with various institutional investors to raise $19.7 million in a private placement of its common stock.

Nomir publishes efficacy of the Noveondual-wavelength device against infectious disease pathogens

Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced today the publication of a scientific paper in the journal Photochemistry and Photobiology that details in vitro and human data demonstrating the unique and patented mechanism-of-action for its Noveon® dual-wavelength device, as well as positive efficacy and safety data.

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

The Icahn School of Medicine at Mount Sinai has launched an international clinical trial called TWILIGHT to test the safety and effectiveness of treating coronary stent patients with the anti-clotting medication ticagrelor alone, instead of combining it with aspirin, which is the current standard of care. Researchers will analyze the potential benefits of administering ticagrelor to reduce clotting while at the same time reducing the risk of bleeding associated with the use of both medications.

Components of insulin-control system can reset body's biological clock

Many of the genes that regulate insulin also alter the timing of the circadian clock, a new study has found.

LSTM professor awarded The Manson Medal for outstanding contribution in field of tropical medicine

The Liverpool School of Tropical Medicine (LSTM) is delighted that Emeritus Professor and Senior Professional Fellow, David Molyneux, has been awarded The Manson Medal, the Royal Society of Tropical Medicine and Hygiene's highest mark of distinction.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Robert Joseph Defatta is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Robert Joseph Defatta, MD, PH D, FACS
1490 Rivers Edge Trail,
Altoona, WI 54720-1495

Ph: (715) 828-2368
Dr Robert Joseph Defatta, MD, PH D, FACS
1490 Rivers Edge Trail,
Altoona, WI 54720-1495

Ph: (715) 828-2368

News Archive

Alexza enters into agreement with institutional investors to raise $19.7 million

Alexza Pharmaceuticals, Inc. announced today that it has entered into a definitive agreement with various institutional investors to raise $19.7 million in a private placement of its common stock.

Nomir publishes efficacy of the Noveondual-wavelength device against infectious disease pathogens

Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced today the publication of a scientific paper in the journal Photochemistry and Photobiology that details in vitro and human data demonstrating the unique and patented mechanism-of-action for its Noveon® dual-wavelength device, as well as positive efficacy and safety data.

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

The Icahn School of Medicine at Mount Sinai has launched an international clinical trial called TWILIGHT to test the safety and effectiveness of treating coronary stent patients with the anti-clotting medication ticagrelor alone, instead of combining it with aspirin, which is the current standard of care. Researchers will analyze the potential benefits of administering ticagrelor to reduce clotting while at the same time reducing the risk of bleeding associated with the use of both medications.

Components of insulin-control system can reset body's biological clock

Many of the genes that regulate insulin also alter the timing of the circadian clock, a new study has found.

LSTM professor awarded The Manson Medal for outstanding contribution in field of tropical medicine

The Liverpool School of Tropical Medicine (LSTM) is delighted that Emeritus Professor and Senior Professional Fellow, David Molyneux, has been awarded The Manson Medal, the Royal Society of Tropical Medicine and Hygiene's highest mark of distinction.

Read more News

› Verified 9 days ago


Otolaryngology Doctors in Altoona, WI

Jens Brown, D.O.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3119 Woodman Dr, Altoona, WI 54720
Phone: 715-717-6700    
Dr. Jeremy C Alderfer, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3119 Woodman Dr, Altoona, WI 54720
Phone: 920-496-4700    
Dr. Rima Abraham Defatta, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 1490 Rivers Edge Trl, Altoona, WI 54720
Phone: 715-828-2368    Fax: 715-839-7796

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.